acalabrutinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadgilbert's syndrome

I am/have/hadmeasurable disease

I am/have/hadlymphoma

I am/have/hadneutrophil count

I am/have/hadprothrombin

I am/have/hadplatelet count

I am/have/hadaptt

I am/have/hadpositron emission tomography

I am/have/hadct scan

I am/have/hadcervical cap

I am/have/hadstage iv grade 2 follicular lymphoma

I am/have/hadinternational normalized ratio

I am/have/hadgrade 3a follicular lymphoma

I am/have/hadtumor cells

I am/have/hadhuman chorionic gonadotropin

I am/have/hadgrade 1 follicular lymphoma

I am/have/hadantibody therapy

I am/have/hadfollicular lymphoma, grade 1

I am/have/hadfollicular lymphoma

added new label for I am/have/had

more

I am looking for

I am looking foracalabrutinib

I am looking forrituximab

I am looking formonoclonal antibodies

I am looking forprothrombin

I am looking forgrowth factor

I am looking forlenalidomide

I am looking forbeta-human chorionic gonadotropin

I am looking forbeta human chorionic gonadotropin

I am looking forhuman chorionic gonadotropin

I am looking fororal contraceptives

I am looking formonoclonal protein

I am looking forbeta-hcg

I am looking forrevlimid

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Acalabrutinib Lenalidomide and Rituximab for the Treatment of CD20 Positive Stage III-IV Grade 1-3a Follicular Lymphoma

This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicular lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

stage iv grade 2 follicular lymphoma

international normalized ratio

grade 3a follicular lymphoma

tumor cells

monoclonal antibodies

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.